Donald Trump's Trial In Defamation Case Brought By E. Jean Carroll To Resume On Thursday, Will Not Be Held On Wednesday
Portfolio Pulse from Benzinga Newsdesk
The defamation trial against Donald Trump, brought by E. Jean Carroll, is set to resume on Thursday, according to court records cited by Reuters. The trial will not take place on Wednesday as previously scheduled.
January 23, 2024 | 8:47 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Digital World Acquisition Corp. (DWAC), associated with Trump, may face volatility due to the resumption of the defamation trial against Donald Trump.
As DWAC is closely associated with Donald Trump, legal developments concerning Trump could impact investor sentiment and cause short-term price fluctuations in DWAC's stock.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 50
NEUTRAL IMPACT
The S&P 500 ETF (SPY) is unlikely to be significantly impacted by the defamation trial against Donald Trump, as it is a broad market index and not directly related to the trial.
SPY represents a broad range of companies in the S&P 500 index, and the trial is not directly related to the ETF's performance or the broader market.
CONFIDENCE 90
IMPORTANCE 10
RELEVANCE 10